Replies to post #383292 on Anavex Life Sciences Corp (AVXL)

[Rubyred77]

Curious who’s the experts of interpreting the data? AF?

[crescentmotor]

I’d rather buy higher and go higher than buy lower and watch my investment go to nothing.

It's fine to play it safe. Millions of folks are satisfied not venturing from the protective boxes they live in and they live small. However, the big rewards and huge successes go to risk takers. That applies to all aspects of life. Investing in early-stage biotechnology companies doesn't have to be a suicide mission--it can return huge rewards if the investor is disciplined and does not put his/her financial security at risk. I've invested in risky early-stage biotech companies for the last twenty-five years--it's been a blast and I've had plenty of setbacks. But to each his/her own as they say.

[tredenwater2]

Then disappoint sets in when Biogen, Eisai and Roche get all the attention while Anavex and 20 other biotechs with promising AD data get no respect

Last I checked uhh, Roche just failed in their drugs target. Biogen successfully went so far as to get a dangerous drug approved only to have it “cancelled”. This second drug will quickly go by the wayside once A 2-73 gets a chance to share their story hopefully with an AA from the Fda.

Its not all about the whistles and inflatable air dancers because imo thats all they have. Instead, its about longevity, safety, actual quality of life improvement, its about regaining ones body’s own ability to heal itself instead of shoving antifreeze in their veins like a lab rat hoping they dont die!

You got two weeks to fit in as many as you can so have at it.